DermTech logo
DermTech DMTK

Annual report 2023
added 02-29-2024

report update icon

DermTech Net Debt 2011-2026 | DMTK

Net Debt can be roughly defined as financial liabilities that an entity classifies in the financing section together with the resources available to service those financial liabilities[1]

Net debt is the obligations that remain after deducting all assets and other liabilities from a company or individual. It represents the sum of debts that an organization or person must repay to their creditors or other parties.

Net debt can include various types of obligations such as loans, borrowings, lease liabilities, or credit card payments. It is important to note that net debt does not include current expenses or obligations such as payroll expenses or current bills.

Assessing net debt is an important financial indicator for evaluating the financial position of a company or individual. If net debt significantly exceeds assets, it may indicate financial difficulties and insolvency. In such cases, the company or individual may face difficulties in meeting their obligations and managing their finances.

Net debt can also be used to compare the financial stability of different companies. The lower the net debt relative to assets, the more stable and financially sound they are considered.

Overall, understanding net debt helps evaluate the financial soundness and ability of a company to meet their obligations. It is an important indicator that assists in making decisions about lending, investments, and financial management.

Annual Net Debt DermTech

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
-33.6 M -76.1 M -175 M -23.9 M -30.5 K -450 K -25 K -16.4 K - - - - -

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
-16.4 K -175 M -38.7 M

References

  1. Pizzo, M., Moscariello, N., & Vinciguerra, R. (2015). Market Incentives and Regulators' Activity Shaping Financial Information: An Analysis of the Net Debt Disclosure in Italy. International Journal of Business and Management, 10(1), 1.

Net Debt of other stocks in the Diagnostics research industry

Issuer Net Debt Price % 24h Market Cap Country
Agilent Technologies Agilent Technologies
A
1.24 B $ 115.48 0.82 % $ 35.1 B usaUSA
Centogene N.V. Centogene N.V.
CNTG
1.18 M - -6.23 % $ 30.6 M germanyGermany
Burning Rock Biotech Limited Burning Rock Biotech Limited
BNR
-76 M $ 16.2 -0.61 % $ 175 M chinaChina
Biodesix Biodesix
BDSX
14.5 M $ 15.07 2.1 % $ 1.95 B usaUSA
Aspira Women's Health Aspira Women's Health
AWH
-512 K - -6.19 % $ 10.5 M usaUSA
Co-Diagnostics Co-Diagnostics
CODX
-10.6 M $ 4.4 101.83 % $ 5.85 M usaUSA
Check-Cap Ltd. Check-Cap Ltd.
CHEK
-11.6 M - - $ 9.42 M israelIsrael
Castle Biosciences Castle Biosciences
CSTL
-108 M $ 24.84 -0.84 % $ 690 M usaUSA
DarioHealth Corp. DarioHealth Corp.
DRIO
9.37 M $ 8.4 3.7 % $ 33.5 M israelIsrael
Oxford Immunotec Global PLC Oxford Immunotec Global PLC
OXFD
-173 M - - $ 562 M britainBritain
BioNano Genomics BioNano Genomics
BNGO
1.19 M $ 1.2 0.84 % $ 6.53 M usaUSA
Akumin Akumin
AKU
1.21 B - -17.87 % $ 25.9 M canadaCanada
Charles River Laboratories International Charles River Laboratories International
CRL
1.98 B $ 173.89 -0.58 % $ 8.62 B usaUSA
Accelerate Diagnostics Accelerate Diagnostics
AXDX
-33.3 M - -61.36 % $ 2.46 M usaUSA
DexCom DexCom
DXCM
-842 M $ 62.22 -0.24 % $ 24.3 B usaUSA
Fulgent Genetics Fulgent Genetics
FLGT
-53.3 M $ 16.82 2.31 % $ 509 M usaUSA
Biomerica Biomerica
BMRA
-1.94 M $ 2.17 -0.91 % $ 4.98 M usaUSA
Global Cord Blood Corporation Global Cord Blood Corporation
CO
-6.07 B - - $ 399 M chinaChina
Celcuity Celcuity
CELC
-28.1 M $ 112.63 -0.27 % $ 5.27 B usaUSA
Fluidigm Corporation Fluidigm Corporation
FLDM
-5.38 M - 1.08 % $ 308 M usaUSA
Genetic Technologies Limited Genetic Technologies Limited
GENE
-11.1 M - - $ 7.1 B australiaAustralia
Genetron Holdings Limited Genetron Holdings Limited
GTH
-1.35 B - 0.12 % $ 80.1 M chinaChina
Exact Sciences Corporation Exact Sciences Corporation
EXAS
-916 M - - $ 19.8 B usaUSA
PRA Health Sciences, Inc. PRA Health Sciences, Inc.
PRAH
769 M - - $ 10.7 B usaUSA
Quest Diagnostics Incorporated Quest Diagnostics Incorporated
DGX
4.92 B $ 198.02 0.17 % $ 22 B usaUSA
Guardant Health Guardant Health
GH
1.15 B $ 93.83 2.94 % $ 11.8 B usaUSA
Enzo Biochem Enzo Biochem
ENZ
-51.3 M - -8.98 % $ 14.8 K usaUSA
Lantheus Holdings Lantheus Holdings
LNTH
213 M $ 76.1 0.53 % $ 5.14 B usaUSA
Biocept Biocept
BIOC
-11.2 M - -13.05 % $ 7.29 M usaUSA
Medpace Holdings Medpace Holdings
MEDP
-360 M $ 498.34 1.81 % $ 14.4 B usaUSA
Heska Corporation Heska Corporation
HSKA
-153 M - - $ 1.31 B usaUSA
HTG Molecular Diagnostics HTG Molecular Diagnostics
HTGM
-11.2 M - -20.0 % $ 1.06 M usaUSA
Interpace Biosciences Interpace Biosciences
IDXG
-1.32 M $ 1.96 5.82 % $ 8.67 M usaUSA
Mettler-Toledo International Mettler-Toledo International
MTD
2.06 B $ 1 259.94 -1.11 % $ 26 B schweizSchweiz
ICON Public Limited Company ICON Public Limited Company
ICLR
4.63 B $ 114.19 2.49 % $ 9.42 B irlandaIrlanda
IDEXX Laboratories IDEXX Laboratories
IDXX
222 M $ 569.55 0.87 % $ 45.8 B usaUSA
Neogen Corporation Neogen Corporation
NEOG
751 M $ 9.41 0.21 % $ 2.04 B usaUSA
Illumina Illumina
ILMN
-494 M $ 127.38 0.59 % $ 20.3 B usaUSA
IQVIA Holdings IQVIA Holdings
IQV
12 B $ 173.26 0.5 % $ 29.8 B usaUSA
Pacific Biosciences of California Pacific Biosciences of California
PACB
-6.67 M $ 1.34 -0.74 % $ 402 M usaUSA
Koninklijke Philips N.V. Koninklijke Philips N.V.
PHG
2.48 B $ 27.11 -0.66 % $ 20 B niderlandNiderland
QIAGEN N.V. QIAGEN N.V.
QGEN
1.31 B - - $ 10.6 B niderlandNiderland
Motus GI Holdings Motus GI Holdings
MOTS
-3.55 M - -34.28 % $ 263 K israelIsrael
Chembio Diagnostics Chembio Diagnostics
CEMI
-17.2 M - 0.22 % $ 16.8 M usaUSA
Laboratory Corporation of America Holdings Laboratory Corporation of America Holdings
LH
4.74 B $ 273.72 0.36 % $ 22.8 B usaUSA
Myriad Genetics Myriad Genetics
MYGN
115 M $ 4.75 3.49 % $ 440 M usaUSA
Sotera Health Company Sotera Health Company
SHC
1.79 B $ 14.96 0.61 % $ 4.25 B usaUSA
NeoGenomics NeoGenomics
NEO
187 M $ 8.0 3.23 % $ 1.02 B usaUSA
National Research Corporation National Research Corporation
NRC
71.3 M $ 17.16 -1.04 % $ 384 M usaUSA